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Abstract
Background: Cancer is a rapidly evolving, multifactorial disease that accumulates numerous genetic and epigenetic
alterations. This results in molecular and phenotypic heterogeneity within the tumor, the complexity of which is further
amplified through specific interactions between cancer cells. We aimed to dissect the molecular mechanisms
underlying the cooperation between different clones.
Methods: We produced clonal cell lines derived from the MDA-MB-231 breast cancer cell line, using the UbC-StarTrack
system, which allowed tracking of multiple clones by color: GFP C3, mKO E10 and Sapphire D7. Characterization of these
clones was performed by growth rate, cell metabolic activity, wound healing, invasion assays and genetic and epigenetic
arrays. Tumorigenicity was tested by orthotopic and intravenous injections. Clonal cooperation was evaluated by medium
complementation, co-culture and co-injection assays.
Results: Characterization of these clones in vitro revealed clear genetic and epigenetic differences that affected growth
rate, cell metabolic activity, morphology and cytokine expression among cell lines. In vivo, all clonal cell lines were able
to form tumors; however, injection of an equal mix of the different clones led to tumors with very few mKO E10 cells.
Additionally, the mKO E10 clonal cell line showed a significant inability to form lung metastases. These results confirm
that even in stable cell lines heterogeneity is present. In vitro, the complementation of growth medium with medium
or exosomes from parental or clonal cell lines increased the growth rate of the other clones. Complementation assays,
co-growth and co-injection of mKO E10 and GFP C3 clonal cell lines increased the efficiency of invasion and migration.
Conclusions: These findings support a model where interplay between clones confers aggressiveness, and which may
allow identification of the factors involved in cellular communication that could play a role in clonal cooperation and
thus represent new targets for preventing tumor progression.
Keywords: Tumor, Breast, Cancer, Metastasis, Heterogeneity, Clone, Communication, Cooperation, MDA-MB-231
Background
Breast cancer is the most common cancer in women
worldwide and the second leading cause of cancer-related
death. In breast cancer, metastatic disease progression car-
ries a poor prognosis, with 5-year survival rates of below
20% [1, 2]. The prognosis is even worse in the case of
triple negative breast cancer (TNBC), which lacks the
major targets of approved therapies, limiting treatment
options to surgery, radiotherapy and/or systemic chemo-
therapy [3].
Breast cancer, like many other malignant tumors, shows
a great molecular and phenotypic heterogeneity, both at
an inter- and intra-tumoral level [4–6]. This heterogeneity
may be understood to be due to the accumulation of mo-
lecular alterations from an initial clone that undergoes
Darwinian selection. During this evolution, certain core
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molecular alterations will be largely governed by cell-
extrinsic phenomena, such as environmental conditions,
including the immune response [7–12]. This mechanism
of tumor evolution has been observed in multiple tumor
types [13–15]. Tumor heterogeneity can result in an in-
complete or incorrect diagnosis when small tumor sam-
ples or biopsies are used; consequently, treatments may be
directed against targets that are not expressed throughout
the entire tumor [16–18].
Furthermore, the genetic-based type of tumor evolu-
tion cannot fully explain how all the functional and
phenotypic alterations required to fulfill Weinberg’s
10 hallmarks of cancer [19] can accumulate within a
single cell clone. For this reason, the theory of clonal
cooperation asserts that tumor clones have comple-
mentary genetic alterations that synergistically con-
tribute to tumor progression and metastasis [20–27].
This clonal cooperation, together with the influence
of the tumor stroma and the immune system, is more
likely to give rise to a functional consortium capable
of altering all the biochemical pathways required for
tumor formation [20].
We therefore reason that analysis of tumor heterogen-
eity should not only be based on genetic alterations (mu-
tations, amplifications, and translocations, among
others) but should be complemented with functional
analysis based on protein expression and pathway ana-
lysis to reveal tumor heterogeneity at the phenotypic
level [15, 28–31]. Phenotypic heterogeneity may also be
caused by non-genetic alterations such as epigenetic
changes or factors secreted from other cells within the
tumor or tumor environment [14, 18, 27, 32, 33]. In
addition, conditions within the tumor, such as hypoxia,
oxidative stress or starvation are not reflected in genetic
alterations, even though numerous adaptive changes
(e.g. metabolism) can be observed within the affected
cells [28]. Since most of these changes are brought about
by altered cell signaling pathways, the evaluation of ex-
pression levels and activity status (e.g. phosphorylation)
of signaling factors is currently the best approach to
monitor functional tumor heterogeneity [14, 28, 32, 34].
In order to study intratumoral heterogeneity and
clonal cooperation on a functional level, we character-
ized the phenotypic features of individual clones isolated
from a breast carcinoma cell line, MDA-MB-231, and
compared these phenotypes with the parental cell popu-
lation. We observed differences in gene expression
among the different clones and were able to link many
of these changes to alterations in cytokine-mediated
intercellular signaling pathways. The importance of these
alterations at the cellular level was demonstrated by
clone-specific phenotypes in vitro and the metastatic po-
tential in vivo. Based on these results, we propose a
model in which clone-specific secretion and reception of
factors allow synergistic growth and ultimately contrib-
ute to tumor progression and metastasis.
Methods
Cell culture and reagents
The study was conducted using the MDA-MB-231 cell line.
This is an epithelial human breast cancer cell line, estab-
lished from a pleural effusion of a 51-year-old Caucasian
woman with metastatic breast adenocarcinoma. The MDA-
MB-231 breast cancer cell line was purchased from the
American Type Culture Collection (ATCC) and authenti-
cated by DNA profiling using short tandem repeat (STR)
(GenePrint® 10 System, Promega) at Genomics Core Facil-
ity, Instituto de Investigaciones Biomédicas “Alberto Sols”
CSIC-UAM. Viral, bacterial and parasitic pathogen analysis
by RT-PCR/PCR was performed at Dynamimed Research
Company: no genetic material was detected. Cells were
maintained at 37 °C in a 5% CO2 humidified incubator
(AutoFlow UN-5510, Nuaire), in Dulbecco’s modified Ea-
gle’s medium (DMEM) (Life Technologies) supplemented
with 10% heat-inactivated fetal bovine serum (FBS) (Bio-
west) and antibiotics (penicillin, streptomycin) (Gibco®-Invi-
trogen). Cells were trypsinized/passaged every 2–3 days
using TrypLE reagent (ThermoFisher Scientific). Cells were
automatically counted using Countess cell counting cham-
ber slides (Invitrogen) and an Eve Automatic cell counter
(NanoEntek), excluding dead cells by trypan blue (Invitro-
gen) staining.
Color-coding (transfection), clone isolation and
fluorescence confirmation
Ubc-StarTrack plasmids and the vector containing the
hyperactive transposase of the PiggyBac system (hyP-
Base) were kindly provided by Dr. López-Mascaraque.
Ubc-StarTrack plasmids were generated as previously
described [35]. MDA-MB-231 cells were treated with
20 μM chloroquine and transfected with 3.5 μg total
UbC-StarTrack plasmid DNA plus 1.2 μg total HypBase
(transposase) DNA, diluted in HBS (HEPES buffered sa-
line). CaCl2 was added to the medium to a final concen-
tration of 150 mM. The medium was changed after six
hours of incubation.
After transfection, the Ubc-StarTrack plasmids and
the transposase under the control of the ubiquitous
CMV promoter enter the nucleus. The Ubc-StarTrack
plasmids are flanked by two terminal repeat sequences
(ITRs) that are recognized and cut by the HypBase. The
released sequence is integrated into the genome of the
transfected cell at TTAA repeat regions, allowing the
cell to stably produce the fluorescent 161 protein (Add-
itional file 1: Figure S1A). This system allows tracking by
color-coding of a complete population derived from the
transfected cell.
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Forty-eight hours after transfection, cells were trypsi-
nized and isolated by fluorescence activated cell sorting
(High Speed Cell Sorter FacsAria (Becton Dickinson)). We
isolated cell clones expressing mT-Sapphire, EGFP, and
monomeric Kusabira Orange (mKO) integrable plasmids.
Cells were individually seeded in a 96 well plate to obtain
clonal cell lines. Non-fluorescent cells were recovered to
be used as a control (MDA-MB-231). The transfection ef-
ficiency was lower than 1%, showing that skewing of the
parental cell line population was avoided. The clonal cell
lines GFP C3, mKO E10, and Sapphire D7 and the MDA-
MB-231 parental cell line were reauthenticated as de-
scribed before. Fluorescence was confirmed on confocal
microscopy (Spectral Confocal Microscope FV1000
(Olympus) and FV10-ASW 4.2 software. For every fluor-
escent protein the following excitation and emission wave-
length settings were used: Ex.405-Em.520 (Sapphire),
Ex.488-Em.520 (GFP), and Ex.515-Em.527 (mKO). After
every trypsinization the percentage of fluorescent cells
was determinate by flow cytometry (LSR Fortessa (BD),
software FCS Express DeNovo), ruling out the possibility
of fluorescent gene silencing.
Contrast phase image capture
Forty-eight hours after seeding, phase contrast images
were taken using an Olympus FSX100 microscope (amp-
lification 40X) and FSX-BSW software.
Cell count
Proliferation was evaluated by direct cell count. Fifty
thousand cells were seeded in a six-well plate. Cells were
trypsinized and automatically counted at the following
time-points: 0 (24 h after seeding), 24, 48, and 72 h.
To calculate the cumulative population doublings
(CPDs), 500,000 cells were seeded in a 100x17mm dish
and trypsinized after 7 days in culture. Cells were counted
and seeded again, repeating the same process for 4 weeks
(28 days in culture). Cumulative population doublings
were calculated using the following formula:
CPDs = [log(n° cells after 7 days) – log(n° seeded
cells)] / log102.
Metabolic activity quantification (MTT assay)
Metabolic activity was evaluated by the MTT (3-[4,5-di-
methylthiazol-25-yl]-2.5-diphenyl tetrazolium bromide;
Panreac-AppliChem) assay. 2500 cells in 150 μL were
seeded in 96-well plates in triplicate and the MTT assay
was performed at time-point 0 (24 h after seeding), and
at 24, 48 and 72 h. MTT was added to the medium to a
final concentration of 0.5 mg/mL and incubated for 3 h
at 37 °C. The medium was aspirated, and the formazan
crystals were dissolved in 0.2 mL DMSO. Absorbance
was measured at 595 nm using an Epoch Microplate
Spectrophotometer (BioTek) and Gen 5 1.10 software.
Spheroid formation assay
3D proliferation was evaluated by sphere growth measure-
ments at 1, 4 and 7 days after seeding. Ten thousand cells
per well were grown in ultra-low attachment 96 well
plates in the presence of 5% Matrigel® (v/v) after 10min of
centrifugation at 2000 rpm. Pictures were taken with an
inverted microscope NIKON Eclipse TE2000–5 and proc-
essed by ImageJ software to measure volume growth.
Caspase assay
Caspase activity was measured using the Caspase-Family
Colorimetric Substrate Set (K132, Biovision). Five hun-
dred thousand cells were seeded in a 100x17mm dish
and trypsinized after 96 h in culture. The pellet was re-
suspended in Cell Lysis Buffer (Biovision) and protein
was quantified by Pierce™ BCA Protein Assay Kit (23,
225, Thermo Fisher). A positive control was included:
MDA-MB-231 cell line treated with Camptothecin (208,
925, Merck) to a final concentration of 25 μg/mL for 24
h. 100 μg protein and pNA conjugated substrate to a
final concentration of 0.5 mg/mL were added to each
well in triplicate and incubated overnight at 37 °C. Ab-
sorbance was measured at 405 nm with an Epoch Micro-
plate Spectrophotometer (BioTek).
Spheroid invasion assay
3D invasion assay was performed by embedding 4-day-
old spheres of each clone in a Matrigel-Collagen I mix-
ture on a pre-coated 24-well plate with the same mix-
ture. Sphere invasion was analyzed by measuring the
invaded area at 24 and 48 h using the inverted micro-
scope NIKON Eclipse TE2000–5 and ImageJ software.
Migration assay
Five hundred thousand cells were seeded per well in 24-
well plates in triplicate. After 24 h, the medium was re-
placed by medium without FBS and maintained over-
night. Then, a wound was made in the monolayer with a
pipette tip, and the medium was replaced with complete
medium. Pictures of the wounds were taken at 0 h and
8 h using an Olympus FSX100 microscope. Wound clos-
ure was measured using ImageJ software. Results repre-
sent the migrated distance between 0 and 8 h, expressed
as a percentage relative to MDA-MB-231.
Transposon insertion event detection and
characterization
Paired-end sequencing raw reads were first processed to
remove PCR duplicates using Fastuniq. Then, we trimmed
the specific Inverted Repeat (IR) associated with the trans-
poson insertion process (GATTATCTTTCTAGGGTTAA,
length = 20) with Trimmomatic [36]. This step was re-
quired to later select those reads that were shorter than
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the original read length (151), implying that they were
covering a transposition event. To map the reads, we
aligned the reads to the human reference genome g1k_v37
[37] using Bowtie 2 and allowing 1 mismatch [38]. Later,
we filtered the alignment with SAMtools [39] to select
paired reads mapped unambiguously with a minimum
alignment quality of 30. The final step of the process relied
on basic shell text processing tools (awk/grep/sed) to sub-
set those pairs where one of the reads presented a length ≤
131 (expected read length after removing the IR) and ex-
tract them from a specific position in the chromosome
representing the first mapped genome base contiguous to
the IR. This list of positions required an additional
prioritization step as the IR sequence was endogenously
found in the human genome. To differentiate these arte-
factual cases from genuine transposition events we took
advantage of one of the transposase properties: they do
not perform even cuts in both reverse/forward strands but
a staggered cut that generates a duplication of 5 bases. A
consequence of this is the representation of a specific in-
sertion event at two positions: n and n + 5. This criterion
was used to depict actual transposition events and define
the set of insertion events that passed to the last step of
characterization. In this last process, we used BEDTools
map function and the annotation related to the human
genome reference selected to map the specific insertion
positions to their genomic context [40].
Analysis of the transcribed genome
The microarray service was carried out at the High Tech-
nology Unit (UAT) at Vall d’Hebron Research Institute
(VHIR), Barcelona (Spain). Affymetrix GeneTitan micro-
array platform and the Genechip Human Clariom D array
cartridges were used for this experiment. This array ana-
lyzes gene expression patterns on a whole-genome scale
on a single array with probes covering many exons on the
target genomes, and thus permits an accurate summary of
gene expression.
1.5 × 106 cells were seeded in a 100x17mm dish in tripli-
cate. After 72 h cells were trypsinized and centrifuged. RNA
was extracted using the PureLink™ RNA Mini Kit (Thermo-
Fisher). Quantification and assessment of RNA purity was
performed using a NanoDrop™ 2000/2000c Spectropho-
tometer and confirmed according to the RIN (RNA Integ-
rity Number) using RNA 6000 Nano Kit and 2100
Bioanalyzer (Agilent). Starting material was 200 ng of total
RNA of each sample. Briefly, sense ssDNA suitable for la-
belling was generated from total RNA with the GeneChip
WT Plus Reagent Kit from Affymetrix (Thermofisher-Affy-
metrix) according to the manufacturer’s instructions. Sense
ssDNA was fragmented, labelled and hybridized to the ar-
rays with the GeneChip WT Plus Terminal Labeling and
Hybridization Kit from the same manufacturer.
All microarray data in this publication have been de-
posited in the NCBI Gene Expression Omnibus and are
accessible through the GEO Series accession number
GSE122008 (https://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE122008).
Bioinformatic analysis was performed at the Statistics
and Bioinformatics Unit (UEB) of the Vall d’Hebron Re-
search Institute (VHIR, Barcelona, Spain). A Robust
Multi-array Average (RMA) algorithm [41] was used for
pre-processing microarray data. Background adjustment,
normalization and summarization of raw core probe ex-
pression values were defined so that the exon level
values were averaged to yield one expression value per
gene. Data were subjected to non-specific filtering to re-
move low variability genes. Conservative thresholds were
used to reduce possible false negative results. Selection
of differentially expressed genes was based on a linear
model analysis with empirical Bayes modification for the
variance estimates [42]. To account for multiple testing,
P-values were adjusted to obtain stronger control over
the false discovery rate (FDR), as described by the Benja-
mini and Hochberg method. The analysis of biological
significance was based on enrichment analysis against
the Gene Ontology (GO; http://www.geneontology.org)
and KEGG (http://www.genome.ad.jp/kegg/) databases.
DNA methylation analysis
Microarray-based DNA methylation analysis was con-
ducted with the Infinium MethylationEPIC BeadChip
microarray (Illumina, San Diego, CA), that covers over 850,
000 CpG methylation sites (850 K). 1.5 × 106 cells were
seeded in a 100x17mm dish in triplicate. After 72 h cells
were trypsinized and centrifuged. Pellets were frozen until
DNA extraction. DNA quality checks, bisulfite modifica-
tion, hybridization, data normalization, statistical filtering,
and beta (β) value calculations were performed as described
elsewhere [43, 44]. The DNA concentration of the samples
was measured using the Quantifluor ONE dsDNA System
(Promega). A total of 500 ng of DNA samples were selected
for bisulfite conversion with the EZ DNA Methylation™ Kit
(Zymo Research). The Illumina Infinium HD methylation
protocol was followed for the hybridization to the Infinium
MethylationEPIC BeadChips. Whole-genome amplification
and hybridization were performed on the BeadChips and
followed by single-base extension and analysis on a HiScan
(Illumina, San Diego, CA) to assess the cytosine methyla-
tion states. The methylation score of each CpG was repre-
sented as β value, and previously normalized for color bias
adjustment, background level adjustment and quantile
normalization across arrays. Probes and sample filtering in-
volved a two-step process for removing SNPs and unreli-
able betas with a high detection P-value > 0.01. Sex
chromosome probes were also removed. After this filtering,
the remaining CpGs were considered valid for the study.
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Cytokine quantification
1.5 × 106 cells were seeded in a 100x17mm dish in tripli-
cate. After 72 h the medium was collected and filtered
through 0.22 μm filters (Merck Millipore) to remove float-
ing cells, apoptotic bodies and cell debris. The concentra-
tions of the cytokines TNF alpha, IFN gamma, IL-1 beta,
IL-2, IL-4, IL-5, IL-6, IL-8, IL-9, IL-10, IL-12p70, IL-13, IL-
17A, GM-CSF, MCP1, MIP1a and MIP1b were determined
using the FirePlex Human Key Cytokines - Immunoassay
Panel (ab229791) by Abcam FirePlex Service Lab.
Complementation assays
To test the presence of factors that could increase prolifer-
ation and metabolic activity, the media where the parental
cell line or a clone were cultured for several days were re-
covered. The medium was tested by two independent as-
says (MTT and cell count). Exosomes were tested by
MTT. “Donors cells” were cultured as follows: 17,600
cells/cm2 (medium complementation) or 10,400 cells/cm2
(exosome complementation) were seeded in 0.17 or 0.1
mL complete medium/cm2, respectively. Twenty-four
hours before treatment the “receptor cells” were seeded:
1250 cells in 150 μL were seeded in 96-well plates in tripli-
cate (MTT assay) or 25,000 cells in 3mL were seeded in
6-well plates in duplicate (cell count). Seventy-two hours
after the “donor” seeding, the medium was recovered. The
medium was filtered through 0.22 μm filters (Merck Milli-
pore) to remove possible floating cells and added to the
“receptor cells” (complete medium, CM). The medium
was also ultracentrifuged to extract exosomes, the super-
natant after two ultracentrifugations was recovered (sol-
uble factors, SF) and the pellets were resuspended in PBS
(exosomes). Exosome protein concentration was quanti-
fied by BCA Protein Assay kit (ThermoFisher).
To perform the direct cell count, donor medium was
added to new medium to a final concentration of 0, 10,
25 and 50%. Cells were counted after 96 h’ treatment.
For the MTT assay, donor medium was added to new
medium to a final concentration of 0, 25 and 50%. MTT
assay was performed at time-point 0 (24 h after seeding),
72 and 96 h. To study the effect of exosomes on cell
metabolic activity, cells were treated with 50% complete
medium and 50% soluble factors as a control. Exosomes
were added to a final concentration of 5, 10, 20, 40, 80
and 160 μg protein/mL. MTT assay was performed at 72
h.
Exosome isolation
Seventeen thousand six hundred cells/cm2 were seeded
in 0.1 mL complete medium/cm2. After 72 h in culture,
supernatant was recovered and sequentially centrifuged
as follows: 500 rcf/10 min, 12,000 rcf/20 min and 100,
000 rcf/90 min (× 2). Finally, each pellet was resus-
pended in PBS.
Protein extraction and immunoblotting
Total protein extracts were generated using RIPA Lysis
Buffer System (sc24948, SantaCruz Biotechnology) supple-
mented with Protease Inhibitor Cocktail set III (539134)
and Phosphatase Inhibitor Cocktail Set II (524625) from
Calbiochem. Protein was quantified using a BCA Protein
Assay kit (23,225, ThermoFisher). Protein extracts (10 μg
per sample) were loaded onto SDS-PAGE gels and elec-
trophoretically transferred to PVDF membranes. The fol-
lowing primary antibodies were used: CD81 (sc-166,028,
SantaCruz Biotechnology), TSG101 (ab83, Abcam) and b-
actin (JLA20, Calbiochem). Goat anti-rabbit and anti-
mouse HRP secondary antibodies were from Pierce Ther-
moScientific (31460) and Calbiochem (JA1200), respect-
ively. Immunodetection of proteins was performed using
Amersham ECL Western Blotting Detection Reagent (GE
Healthcare).
Transmission electron microscopy
Exosomes were characterized by transmission electron
microscopy (TEM), using negative staining. Electron mi-
croscopy images were recorded on a T20-FEI Tecnai ther-
moionic microscope operated at an acceleration voltage of
200 kV. Negative stained samples were prepared by drop-
ping 20 μL of sample onto carbon coated copper grids
(200 mesh), which were then dried at room temperature
and stained with phosphotungstic acid. Exosome size was
measured using ImageJ software.
Co-culture assay
MDA-MB-231, GFP C3, mKO E10 and Sapphire D7 cell
lines were cultured as individual cell lines and as combina-
tions, with 2, 3 and 4 cell lines in co-culture. The co-
cultures started with equal percentages of every clone. Five
hundred thousand total cells were seeded in a 100x17mm
dish and trypsinized after 7 days in culture. Cells were
counted and seeded again, repeating the same process for
4 weeks (28 days in culture). After every trypsinization the
percentage of every cell line per co-culture was determinate
by flow cytometry (LSR Fortessa (BD), software FCS Ex-
press DeNovo). CPDs were calculated as previously de-
scribed. Expected CPDs were calculated using data from
the individual plates (single culture). Observed CPDs were
calculated using data from every co-culture.
Arsenite resistance assay
Two hundred thousand total cells were seeded in a
60x17mm dish. 24 h after seeding, cells were treated for
90 min with 250 μM Arsenite (NaAsO2 in complete
medium). After treatment, cells were washed twice with
PBS and new complete medium was added. Cells were
counted after 72 h.
The co-culture experiment was performed in the
presence of arsenite. The co-cultures started with equal
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percentages of every clone (100,000 cells per clone):
MDA-MB-231 + GFP C3 or MDA-MB-231 + mKO E10.
24 h after seeding, cells were treated as detailed before.
The percentage of each cell line in the total population
was detected by flow cytometry at seeding (day 0), 90
min (day 1) and 72 h (day 4) after treatment.
Invasion assay
8-μm pore inserts were covered with 65 μL Matrigel
(356,231, Corning) at a final concentration of 1.5 mg/
mL. Matrigel was incubated for 4 h at 37 °C. Once the
Matrigel was polymerized over the Matrigel layer, 30,000
cells were seeded in 100 μL medium without FBS.
Complete medium (supplemented with FBS, which stim-
ulates the cells to cross the Matrigel layer) was added to
the well under the insert, covering the bottom of the in-
sert. Twenty-four hours after seeding, cells were fixed
with PFA 4% and counterstained with Hoechst. The top
of the insert was cleaned with a cotton bud to remove
the Matrigel and any cells that did not cross the layer.
Images were taken of the entire insert bottom where the
invading cells were located, using an Olympus FSX100
microscope (amplification 4.2X) and FSX-BSW software.
Following the previous description, we performed two
different invasion assays, with co-culture and with
medium complementation. Modifications to the previ-
ous protocol are detailed as follows:
(1) Co-culture: GFP C3 and mKO E10 were seeded as
single cell lines and as an equal combination of
both cell lines.
(2) Medium complementation: GFP C3 and mKO E10
were seeded as single cell lines. Complemented
complete medium was added to the well under the
insert, covering the bottom of the insert.
Complemented medium was obtained as detailed in
“Complementation assays”.
Animal experimentation
Female athymic nude mice (Strain: Hsd:Athymic Nude-
Foxn1nu) (ENVIGO, Spain) were kept in pathogen-free
conditions and used at 7 weeks of age. Animals were
randomly housed under Specific Pathogen Free (SPF)
conditions in autoventilated racks in groups of six. Two
enrichment elements were included, a cardboard tube
and a square nestlet for nesting and thermoregulation.
The housing temperature ranged from 23 °C to 25 °C,
relative humidity ranged between 47 and 55%. The cycle
gradually simulates twilight and sunset, giving 12 h of
light with an intensity of 300 Lux and 12 h of darkness
for each 24 h period. Food and water were provided ad-
libitum. Animal care was handled in accordance with
the Guide for the Care and Use of Laboratory Animals
of the Vall d’Hebron University Hospital Animal Facility,
and the experimental procedures were approved by the
Animal Experimentation Ethics Committee at the insti-
tution (76/17 CEEA). Body weight and physical appear-
ance of the animals were monitored twice a week. The
animals were euthanized by cervical dislocation follow-
ing the euthanasia standard operating procedure (SOP)
of Laboratory Animals of the Vall d’Hebron University
Hospital Animal Facility. All the in vivo studies were
performed by the ICTS ‘NANBIOSIS’, more specifically,
by the CIBER-BBN in vivo Experimental Platform of the
Functional Validation & Preclinical Research (FVPR)
area (Barcelona, Spain).
The implanted cells were the MDA-MB-231 parental
cell line, three in vitro isolated clones (mKO E10, GFP C3
and Sapphire D7), both individually and as a mix of the
four lines in a ¼ ratio. The parental cell line was included
in the mix to provide factors probably not produced by
the clonal cell lines and which may be needed for tumor
growth and/or metastasis. All cell variants were confirmed
to be negative for viral, bacterial (including mycoplasma)
and parasitic pathogens (VHIR Screening Humano Com-
pleto). The test was performed by the external reference
laboratory Dynamimed Research Company. Prior to the
injection, the percentage of fluorescent cells was quanti-
fied by flow cytometry, to confirm the injected cells
expressed the fluorophore and exclude the possibility of
fluorescent gene silencing.
The tumor growth rate and invasive capacities were eval-
uated by implantation of 2.5 × 106 cells into the right ab-
dominal mammary fat pad (i.m.p.f.) of twelve animals per
group (five groups). The tumor volume was measured by
caliper measurements twice a week and calculated accord-
ing to the formula D× d2/2, where D is the largest diameter
of the tumor and d the smallest one. All animals were eu-
thanized 34 days after inoculation to compare the primary
tumor size and composition and the number and extent of
lung metastases between groups. The tumors and lungs
were weighed, fixed with paraformaldehyde 4%, and later
processed for histopathological analyses (hematoxylin and
eosin staining).
The metastasis growth rate of the MDA-MB-231
and clonal cell lines was evaluated by intravenous
(IV) injection of 2.5 × 106 cells into the caudal tail
vein of 10 animals per group (five groups). All ani-
mals were euthanized 36 days after inoculation. Ani-
mals underwent gross necropsy consisting of a
macroscopic evaluation. Lungs were excised, weighed,
fixed and processed for histopathological analysis.
Immediately following dissection, the tumors and lungs
were fixed for 24 h by immersion in paraformaldehyde 4%.
After fixation, the tissue was dehydrated to enable embed-
ding with paraffin. Five-micron-thick sections were cut
from fixed, paraffin-embedded tissues and mounted
on poly-L-lysine-coated glass slides. Sections were
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deparaffinized in xylene and rehydrated in graded al-
cohol. The presence of clonal cells in the primary
tumor and metastases were detected by fluorescence
on confocal microscopy (Spectral Confocal Micro-
scope FV1000 (Olympus)). To avoid spectral overlap-
ping of the different fluorescent proteins, a Lambda
scan was performed from 470 to 635 nm followed by
spectral deconvolution using FV10-ASW 4.2 software.
Images were quantified using the program ImageJ.
In vivo zebrafish tumor xenograft assays
Zebrafish (Danio rerio) embryos were generated by nat-
ural mating of adult fish according to previously de-
scribed procedures (Westerfield, 2000). In order to
remove surface pigmentation, embryos were incubated
with PTU (N-Phenylthiourea, Sigma) at a 0.003% w/v con-
centration and maintained at 28 °C. For xenograft experi-
ments, 2 days postfertilization (dpf) zebrafish embryos
were de-chorionized if necessary and anaesthetized with
0.003% tricaine (Sigma) w/v in E3 water and positioned
on a 10 cm Petri dish coated with 1.5% agarose. Immedi-
ately prior to injection, single cell suspensions of MDA-
MB-231-GFP C3 cells and MDA-MB-231-mKO E10 cells
were labelled with the lipophilic fluorescent tracking dyes
CM-DiD and CM-DiI (Invitrogen) respectively, according
to manufacturer’s instructions. To remove unincorporated
dye, cells were centrifuged and rinsed twice with Dulbec-
co’s phosphate-buffered saline (DPBS). Cells were kept on
ice before implantation and implanted within 3 h. For
microinjection, the individual cell populations (individual
injection) or the combination of both at equal numbers
(co-injection) were loaded in borosilicate glass capillary
needles (1mm O.D. × 0.58mm I.D, Harvard Apparatus)
and approximately 300 cells were injected into the duct of
Cuvier (DoC) using a micromanipulator and an IM 300
microinjector (Narishige) with an output pressure of 10
psi and 0.03ms injection time. After injection, embryos
were examined for the presence of a fluorescent cell mass
at the injection site in the DoC, and then transferred to
fresh PTU-containing E3 water and placed into an incuba-
tor at 34 °C for up to 3 days post injection (dpi). Zebrafish
embryos were photographed at 0 h post injection (hpi)
and 72 hpi with a fluorescent microscope DMi8 (Leica) to
determine tumor cell dissemination. The number of
tumor cells disseminated in the tail vein of the fish was
analyzed with the software ImageJ Fiji. For each condition,
data are representative of at least three independent ex-
periments, with at least 30 embryos per group.
Statistics
Prism 5.0 software (GraphPad Software Inc., La Jolla, CA)
was used for statistics and data representation. Significant
differences were determined using unpaired t-test with
Welch’s correction (equal SDs not assumed) and ANOVA
(Tukey’s multiple comparisons test). Individual figure leg-
ends specify the test used in each case. Asterisks indicate
significant differences when P-values are < 0.05 (*), < 0.01
(**), and < 0.001 (***).
Graphics
Graphics were created using Prism 5.0 software and
Adobe® Illustrator CC.
Results
Generation of color-coded clonal cell lines derived from
the MDA-MB-231 cell line
In order to study tumor heterogeneity in a cell culture-
based model, we selected the triple negative human breast
cancer (TNBC) cell line MDA-MB-231. The presence of
genetically and phenotypically different clonal populations
has previously been described in this line [45]. To allow us
to study individual clonal populations and trace their fate
during tumor progression, cells were color-coded according
to the expression of fluorescent proteins [46, 47]. Genomic
integration of fluorescent protein-encoding sequences was
achieved by the use of the UbC-StarTrack PiggyBac trans-
poson system (Additional file 1: Figure S1a) [35, 46]. To
generate the color-coded cell lines, we used different
transposon-containing plasmids that encode for the fluores-
cent proteins mT-Sapphire, EGFP and mKO (Additional
file 1: Figure S1b). From the clonal cell lines, we selected
GFP C3 (EGFP), mKO E10 (mKO) and Sapphire D7 (mT-
Sapphire) for further study, each of which expresses one
fluorescent protein (Additional file 1: Figure S1c). Addition-
ally, FACS-sorted non-fluorescent cells were pooled and
grown as a control population (named MDA-MB-231, par-
ental). The transfection efficiency was lower than 1%, show-
ing that skewing of the parental cell line composition was
avoided. Finally, cell line authentication by DNA profiling
of short tandem repeats (STR) confirmed that all obtained
clones were derived from the parental cell line MDA-MB-
231 (Table 1).
To confirm the presence of heterogeneity in the
MDA-MB-231 cell line and to validate our approach of
studying tumor heterogeneity in a cell line-based model,
we characterized different phenotypic features of the in-
dividual clonal cell lines.
Cell morphology
MDA-MB-231 is an epithelial cell line, characterized by
elongated polygonal cells. Although all clonal cell lines
maintained an epithelial morphology, the shape of the
cells varied between the different clones, the clone mKO
E10 being the most different to the others, with more
polygonal and less elongated morphology (Fig. 1a, Add-
itional file 2: Figure S2a).
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Cell growth
Cell growth was determined by counting the number of
viable cells in an exponentially growing culture 72 h after
seeding. As shown in Fig. 1b, the growth rate of GFP C3
was similar to that of the parental cell line. In contrast, the
clones mKO E10 and Sapphire D7 had a reduced growth
rate of up to 40 and 30%, respectively, compared to the
parental cell line. These results were confirmed by meas-
uring the metabolic activity of the cells via MTT assay
(Fig. 1c). To confirm these results were not a consequence
of 2D culture, we performed spheroid 3D culture. The re-
sults were confirmed, showing an even greater growth rate
reduction in 3D culture than in 2D culture for mKO E10
and Sapphire D7 (Fig. 1d-e). With the aim of determining
if this phenotype is heritable, we cultured the different cell
lines for 28 days and calculated the cumulative popula-
tions doublings (CPDs) after 7, 14, 21 and 28 days in cul-
ture (Additional file 2: Figure S2b). Cell lines maintained
stable proliferation rates over time.
Apoptosis
In order to assess if the reduction in cell growth was due
to increased cell death, we determined the activation of
caspase 1 activity, known to induce pyroptosis, a lytic
form of cell death. While the clone mKO E10 showed
some activation of caspase 1, a striking increase of cas-
pase 1 activity was observed in the clone GFP-C3 (Fig.
1f ). The activity of caspases [2, 3, 6, 9] was measured as
a readout for the activation of pro-apoptotic signaling
pathways. In comparison to the parental cell line MB-
MDA231, cells of the clonal cell lines GFP C3, mKO
E10 and Sapphire D7 exhibited significantly higher levels
of these caspases (Fig. 1g).
Cell growth was measured by cell counting after 72 h
in culture. Cell growth is the net result of proliferation
and cell death. GFP C3 may have had increased apop-
tosis that was compensated by higher proliferation; in
contrast, cell growth in low-growth-rate cell lines would
be the result of decreased proliferation, rather than in-
creased apoptosis.
Cell migration
The wound healing assay was used to measure cell mi-
gration, which is essential for many biological processes
including tumor invasion and metastasis [48]. The ana-
lyzed clonal cell lines had similar migratory capacity to
the parental cell line (Additional file 2: Figure S2c-d).
Invasion
Spheres assembled in 3D cultures were embedded in a
Matrigel/collagen matrix and the expansion of the spheres
into the matrix was determined microscopically. Analysis
of the obtained data revealed that, while the invasive cap-
acity of the clones GFP and Sapphire was similar to the
parental cell line, cells from the clone mKO had a reduced
invasion rate of up to 50% into the matrix (Fig. 1h-i).
Tumorigenicity and metastasis of clonal cell lines
Tumorigenicity of clonal cell lines
Having established that the isolated clonal cell lines dis-
played phenotypic heterogeneity in vitro, we next analyzed
their tumorigenic potential in vivo. We orthotopically
injected the clones individually (GFP C3, mKO E10, Sap-
phire D7 or the parental MDA-MB-231 cell line) and in
combination (mix of clones and parental cell line, 25%
each) into the mammary fat pad of immunocompromised
Table 1 Authentication profile for the selected clones vs. MDA-MB-231 parental cell line. Characterization of the clonal cell lines
(GFP C3, mKO E10 and Sapphire D7) versus parental cell line (MDA-MB-231, also named ATCC® HTB-26) by STR profile evaluation
(first column): number of shared alleles and percent match
STR profile Expected:
ATCC® HTB-26
MDA-MB-231 GFP C3 mKO E10 Sapphire D7
D5S818 12 12 12 12 12
D13S317 13 13 13 13 13
D7S820 8,9 8 8 8 8
D16S539 12 12 12 12 12
vWA 15,18 15 15 15,16 15
TH01 7,9.3 7,9.3 7,9.3 7,9.3 7,9.3
TPOX 8,9 8,9 8,9 8,9 8,9
CSF1PO 12,13 12,13 12,13 12,13 12,13
D21S11 30,33.2 30,33.2 30,33.2 30,33.2 30,33.2
Amelogenin x x x x x
Number of shared alleles 14 14 14 14
Number of alleles in database 16 16 16 16
Percent match 87% 87% 87% 87%
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Fig. 1 (See legend on next page.)
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nude mice. Surprisingly, despite the differences observed
for these clones in vitro, all of the clonal cell lines formed
primary tumors, and the tumor growth rates were similar
for all individual clonal lines and the parental cell line
(Fig. 2a-b). Similar results were observed when the cell
clones and parental cell line were co-injected as a mixture
(Fig. 2a-b).
Despite the similar tumor growth rates, we wondered
if the tumors would have morphological differences.
Pathological examination of the tumors revealed that the
primary tumor cells from the different cells lines were of
a similar shape, but with subtle differences. Cells within
the mKO E10-derived tumors displayed a more rhab-
doid, plasmacytoid shape, Sapphire D7 being the more
compact tumor, formed by particularly small, round cells
(Fig. 2c). Thus, despite similar tumor growth rates,
tumor cell shape varied slightly, depending on the origin
of the clones.
The tumors formed after co-injection of the different
clonal cell lines and the parental cell line were assessed
on confocal microscopy. As shown in Fig. 2d-e, the
clonal composition varied depending on the section ana-
lyzed, and the individual clones showed variable inter-
mixing (Fig. 2d). Figure 2e shows the number of
fluorescent clonal cells and the parental cells (not ex-
pressing fluorescent proteins) in the analyzed sections.
Interestingly, the parental cells were predominant, while
the clones GFP C3 and Sapphire D7 were detected in
various areas of the tumor and few mKO E10 cells were
observed (Fig. 2d-e). Finally, cell counting of different
sections of the whole tumor revealed that the majority
of fluorescent clone cells within the tumor were either
GFP or Sapphire positive (46.96 and 49.74%, respect-
ively) and only 3.3% of the cells were derived from the
clone mKO E10 (Fig. 2e). Considering that all the clones
had similar growth rates when injected individually into
the mice, this finding indicates that the interplay among
the different clones determines their fate during tumor
progression.
Metastatic tumor formation capacity
We next analyzed the ability of the clones to form metas-
tases derived from the orthotopic tumor. The lungs of the
sacrificed mice were stained with hematoxylin/eosin, and
microscopy revealed that, although cells from all clonal
cell lines were able to form metastases, the metastasis
count was significantly lower in the mKO E10 clonal cell
line (Fig. 3a).
To confirm these results, we determined the meta-
static capacity of the individual cell lines in the lungs of
the mice after tail vein injection. Measurement of the
metastatic areas within the lungs confirmed the reduced
capacity of mKO E10 to form metastases (Fig. 3b, Add-
itional file 3: Figure S3). The lungs were weighed as an
indirect measurement of the presence of metastases, and
the results were confirmed by area measurement (Fig.
3c). These results indicate that the inability of these cells
to form metastases might be due to their homing or sur-
vival in the lungs. We think that the mKO E10 cell line
would be an appropriate subject of future research on
targeted therapies.
Hematoxylin/eosin stained lung sections confirmed
inter-individual heterogeneity, in the percentage of lung
area occupied by metastases formed by MDA-MB-231
(Mean ± SEM 25.14% ± 11.14), GFP C3, (19.42% ± 6.41),
mKO E10 (0.25% ± 0.20), Sapphire D7 (10.07% ± 2.95)
and Mix (8.54% ± 3.78) (Fig. 3b). Photographs showing
the variability among individual animals are shown in
Additional file 3: Figure S3.
In addition to determining the metastatic capacity of
the individual clones, our experimental setup of the
mixed clonal populations also allowed us to determine if
macrometastases were formed from individual or mul-
tiple cells. We used confocal microscopy to analyze the
metastases induced by an equal mix of the parental cell
line and clonal cell lines (Fig. 3d). mKO E10 cells were
not found in the resulting metastases. Fluorescence re-
vealed the metastases could be formed by one (Fig. 3d)
or more than one clone (Fig. 3e). However, even in me-
tastases formed by more than one clone, we found a
main component formed from a single clone.
Molecular characterization of clonal cell lines by gene
expression, methylomics and cytokine expression
Gene expression profiling by microarray analysis
To uncover the molecular mechanisms of interplay be-
tween different clones in a heterogeneous population,
(See figure on previous page.)
Fig. 1 Phenotypic characterization of MDA-MB-231, GFP C3, mKO E10, and Sapphire D7 cell lines. a Morphological evaluation by phase contrast
images (scale bar = 200 μm). b Cell count after 72 h in culture, relative to MDA-MB-231 count. c Metabolic activity rate: quantification of MTT
metabolization by metabolically active cells, absorbance relative to MDA-MB-231. d-e 3D growth rate: spheroid area at days 1, 4 and 7, relative to
MDA-MB-231-day 0 quantification (d) and representative pictures (scale bar = 250 μm) (e). f-g Apoptotic analysis: absorbance relative to MDA-
MB231. Expression of Caspase 1 (f) and Caspase 9, 3, 2 and 8 (g). h-i 3D invasion by spheroid cell migration: relative invasion (h) and
representative picture at 0 and 48 h (scale bar = 250 μm) (i). Significant differences were determined using unpaired t-test with Welch’s correction.
Asterisks indicate significant differences when P-values are < 0.05 (*), < 0.01 (**), and < 0.001 (***)




Fig. 2 (See legend on next page.)
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microarray analysis was performed to determine the
relative alterations in gene expression profiles of the
clonal cell lines in comparison to the parental cell line
MDA-MB-231(Fig. 4).
Variation at the level of individual transcripts was quan-
tified by identifying which genes had a statistically signifi-
cant difference in expression level from average (p < 0.1)
and expressing these in a heatmap. As depicted in Fig. 4a,
significant differences in the gene expression profiles were
detected between the different clonal cell lines and the
parental cell line. Statistically significant differences in
gene expression compared to MDA-MB-231 cells were
determined, separated into up- and downregulated genes
and displayed as a Venn diagram (Fig. 4b-c). The most
striking differences were observed for the clone mKO E10:
1017 genes were downregulated, and 288 genes were up-
regulated, while the clonal cell lines GFP C3 and Sapphire
D7 had fewer regulated genes (GFP C3, 262 down and 71
(See figure on previous page.)
Fig. 2 Malignancy of individual clones and tumor heterogeneity. a-c Tumor growth over 34 days after orthotopic injection of MDA-MB-231, GFP
C3, mKO E10, or Sapphire D7 clonal cell lines and an equal mix of the previous cell lines (mix): (a) volume relative to MDA-MB-231 tumors (n = 12
per group), (b) macroscopic images of the tumors (scale bar = 0.5 cm) and (c) hematoxylin/eosin stains of tumor sections (scale bar = 50 μm)
(three different animals per cell line: ID1, ID2, ID3). d-e Tumor heterogeneity: (d) representative fluorescent images (scale bar = 50 μm) of three
independent sections of tumor formed by MDA-MB-231 parental and GFP C3, mKO E10 and Sapphire clonal cell lines (mix) and (e) quantification
of tumor composition formed by the clonal cell lines (n = 6). Significant differences were determined using unpaired t-test with Welch’s
correction. Asterisks indicate significant differences when P-values are < 0.05 (*), < 0.01 (**), and < 0.001 (***)
Fig. 3 Metastatic capacity of cell lines and an equal mix of all cell lines. a Absolute count of micrometastases derived from orthotopic primary
tumors, 34 days after injection of tumor cells. b-c Metastasis growth induced 35 days after intravenous injection of tumor cells: (b) lung area
occupied by metastases, and (c) lung weight, an indirect measurement of lung tumors. Significant differences were determined using unpaired t-
test with Welch’s correction. Asterisks indicate significant differences when P-values are < 0.05 (*), < 0.01 (**), and < 0.001 (***). d-e Representative
fluorescent images (scale bar = 50 μm) of four independent sections of lung metastasis formed by MDA-MB-231 parental and GFP C3, mKO E10
and Sapphire clonal cell lines (mix)
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up; Sapphire D7, 106 down and 40 up), in comparison to
the parental cell line (Fig. 4b-c).
To elucidate which alterations in gene expression
could potentially account for the observed phenotypic
differences in vitro and in vivo, we performed bioinfor-
matic analysis. We narrowed down the number of po-
tential candidates using gene ontology and KEGG
pathway analysis to identify the pathways and biological
processes that were altered in the different clones (Fig.
4d-e). Gene ontology (GO) revealed both common and
clone-specific changes in biological processes (Fig. 4d).
Most of the changes occurred in the expression levels of
genes involved in signaling cascades. Interestingly, many
of the genes identified within the class of signaling fac-
tors also belonged to the GO term “cytokine-mediated
signaling pathways”, the third most abundant class of
pathway affected in the analysis. Therefore, intercellular
communication via cytokines and their respective down-
stream signaling pathways displayed the greatest differ-
ences between clonal cell lines and the parental MDA-
MB-231 cells. Following this line, we were able to iden-
tify cytokines and cytokine receptors that showed alter-
ations that were either common to the parental cell line
or clone-specific. The detection of specific signaling
pathways in the analysis, namely NOD, Toll-like recep-
tor and JAK-STAT signaling pathways, was also due to
the cytokines and their receptors, acting upstream of the
respective pathways. KEGG pathway analysis confirmed
these findings (Fig. 4e).
To elucidate why the clone mKO E10 had a non-
metastatic phenotype, we matched our dataset with the
Human Cancer Metastasis Database. This analysis re-
vealed that of the 658 genes with altered mRNA expres-
sion in the clone mKO, 95 have been linked to
metastasis (Additional file 4: Table S1). Among the genes
with the biggest alterations compared to the parental cell
line was TGF-beta receptor type-1 (TGFR-1, log2FC
-0.9). TGF-beta receptor signaling has been strongly
linked to metastatic disease progression in breast cancer,
so downregulation of TGFR-1 in the clone mKO might
have been the reason for the non-metastatic phenotype
[49, 50]. Detailed analysis of these and other potential
factors will be required in the future to determine how
their altered expression can affect metastatic disease
progression.
Transposon sequencing
In order to test if the observed changes in gene expres-
sion profiles reflected a natural heterogeneity within the
MDA-MB-231 cell line, or if these changes were induced
by genomic alterations through the insertion of transpo-
sons, we performed genomic DNA sequencing, mapping
the exact insertion sites of the transposons. We detected
multiple insertions of the same transposon into the gen-
omic DNA, but, excepting one insertion in the Sapphire
D7 clone, these insertions were located in non-coding
genomic regions (introns). Analysis of the microarray
data confirmed none of the insertions affected the corre-
sponding gene expression with respect to MDA-MB-231
parental cell line (Table 2).
In summary, even though all clonal cell lines were de-
rived from the same parental cell line, their mRNA ex-
pression profiles varied widely, and this variation was not
caused by genomic mutations via transposon insertion.
We can therefore conclude that heterogeneity within the
MDA-MB-231 is present at the level of gene expression.
Epigenetic alterations of gene expression
Epigenetic mechanisms, such as DNA methylation,
are important regulators of gene expression. To estab-
lish if the observed changes in gene expression were
due to DNA methylation modifications, we deter-
mined the genomic methylation pattern of the indi-
vidual clones and the parental cell line (Fig. 5). To
extrapolate data from these measurements that are
probably responsible for the observed changes in gene
expression, we focused our analysis on CpG islands
and shore regions of gene promoters. The most dif-
ferentially methylated CpGs in these regions are
shown in the heatmap in Fig. 5a. The comparative
analysis of the methylation signature revealed specific,
characteristic methylation patterns for the individual
clones and for the parental cell line MDA-MB-231.
To determine if these changes caused the observed
alterations in gene expression, we analyzed the associ-
ation between gene expression levels and the methyla-
tion status of their promoter regions. As represented
in Fig. 5b-c, changes in the methylation patterns were
linked to discrete changes in the expression of the re-
spective genes. Downregulated gene expression corre-
lated to hypermethylation of the promoter in 40%
(GFP), 19% (mKO) and 25% (Sapphire) of cases (Fig.
5b). We also observed changes in gene expression
that were common to the different clonal cell lines.
Four altered methylation patterns could be linked to
similar changes in gene expression in two of the
clonal cell lines, and two altered methylation patterns
were linked to gene expression changes in all three
clones (Fig. 5d).
In summary, the observed alterations in gene expres-
sion patterns could indeed be partly linked to different
epigenetic states of the cell. Notably, changes in the
methylation patterns often affect the expression of genes
that act upstream of signaling cascades. It is therefore
plausible to assume that changes in the methylation pat-
tern of core regulatory genes may play a crucial role in
the observed alterations in gene expression (Fig. 5e-f ).
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Cytokine arrays
To confirm these alterations of cytokine-mediated sig-
naling pathways at the protein level, we used cytokine
arrays to analyze the composition of secreted factors
in the individual clones (Fig. 6a). Among the 17 key
cytokines tested, quantifiable amounts were detected
for IL8, IL6, MCP1(CCL2), GM-CSF and IL13.
Among those, MCP1 was reduced more than 10-fold
in all clonal cell lines compared to the parental cell
line. Weaker but still significant alterations were de-
tected for GM-CSF and IL6. Clone-specific differences
were detected for IL8, which was strongly reduced in
the clones mKO E10 and GFP but unaltered in the
clone Sapphire, and higher levels of IL13 were de-
tected in the GFP C3 and mKO E10 clonal cell lines.
To complete this analysis, we merged two datasets
(cytokine expression and mRNA receptor expression)
to elucidate which cytokine-cytokine receptor interac-
tions had observable changes between the parental
cell line and the different clonal cell lines (Fig. 6b).
This comparison revealed that cytokine-mediated sig-
naling pathways might be affected by altered expres-
sion of cytokine receptors, amount of cytokines
released, or by simultaneous changes in cytokines and
cytokine receptors.
Interplay between the different clones
Co-culture experiments
Co-culture experiments were performed to test if the co-
operation between different clones might affect the
growth rate of the individual clones. MDA-MB-231,
GFP C3, mKO E10 and Sapphire D7 cell lines were cul-
tured individually and in different combinations for 28
days (Fig. 7, Additional file 5: Figure S4a-c). In line with
the results obtained in the in vivo mouse model (Fig.
2e), the mKO clonal cell line was progressively reduced
and after 28 days of co-culture was severely depleted,
representing just 3% of the total population (Fig. 7a,
Additional file 5: Figure S4a). The decrease of mKO cells
when mixed with the parental cells may indicate that its
growth is overtaken by that of other clones. This result,
and the result for Sapphire D7, matched the expected
values determined by the calculated cumulative popula-
tion doublings (CPDs) from culture of the individual cell
lines (Fig. 7b). In contrast, the percentage of cells from
the clone GFP C3 was significantly lower than the ex-
pected values (Fig. 7a). The proliferation rate of MDA-
MB-231 and GFP C3 was not significantly different in
single culture (Fig. 1b); however, the increase of CPDs
for MDA-MB-231 in co-culture (Fig. 7a) induced a sig-
nificant decrease of the clone GFP C3 in the total popu-
lation (Fig. 7b). After 28 days in culture, the percentage
of MDA-MB-231 in the population was 28% higher than
expected, while the observed percentage of GFP C3
(14.72%) was lower than expected (39.94%) (Fig. 7a).
These results were confirmed in experiments in which
only the parental cell line and the clone GFP-C3 were
combined (Additional file 5: Figure S4b-c). In all combi-
nations involving GFP C3, the observed percentages of
MDA-MB-231 increased and GFP C3 decreased.
Resistance to stress in co-culture experiments
We show in Additional file 5: Figure S4b how the pres-
ence of clonal cell lines with slower proliferation in the
total population tends to decrease as time in co-culture
increases. In the absence of stressors, such cells would
be outcompeted after several weeks in co-culture. We
aimed to test why these slower-proliferating cells were
still present when we sorted the parental cell line. We
hypothesized that cells could persist in the population
was subject to a stressor that provided any benefit to the
slower cell line or any disadvantage to the faster-
proliferating cell lines. In Additional file 5: Figure S4d
we show that mKO E10 was the clonal cell line most re-
sistant to arsenite treatment, followed by GFP C3 and
Sapphire, MDA-MB-231 being the least resistant. We
wondered how the co-cultured population would evolve
in the presence of this stressor. Additional file 5: Figure
S4e-f shows how the percentage of clones (GFP C3 or
mKO E10) in co-culture was significantly higher (and
consequently, the percentage of MDA-MB-231 cells was
lower) in the presence of arsenite than in the absence of
arsenite. The clone population increases because they
are more resistant than MDA-MB-231. We have in-
cluded this as an example of a stressor, but other
stressors could also affect the resistance of the clones,
for example, resistance to growth from a single cell (sub-
cloning). This allows us to explain why slower-
proliferating clones were present in the MDA-MB231
cell line when we selected them, as they could be more
resistant to a particular stressor than the whole popula-
tion, and thus persist. Therefore, our results show that
maintenance in the total population it is not only
dependent on the proliferation rate; environmental con-
ditions can affect the presence of the clones.
(See figure on previous page.)
Fig. 4 Transcriptional profile of MDA-MB-231 clonal cell lines. a Heatmap for P-value under 0.05 and absolute logFC> 1.5 of selected clonal cell
lines. b-c Venn diagrams of downregulated (b) and upregulated (c) transcripts of selected clonal cell lines vs. MDA-MB-231. d Gene ontology (GO)
with differentially expressed genes (logFC> 1 and FDR < 0.05) of each clonal cell line vs. MDA-MB-231 cell line. e KEGG with differentially
expressed genes (logFC> 1 and FDR < 0.05) of each clonal cell line vs. MDA-MB-231 cell line
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Fig. 5 (See legend on next page.)
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Clonal cooperation on migration and invasion assays
In addition to clonal cooperation by secreted factors,
cells of a heterogenous tumor might use feature comple-
mentation to achieve complex cellular processes like in-
vasion into the cellular matrix – for which not only cell
migration, but also digestion of the extracellular matrix
and chemotactic abilities are required.
To test if our cell line model could reproduce such a
complementary behavior between different clones, we
tested the invasive capacity of the phenotypically more
distinct clones, mKO E10 and GFP C3, alone and in
combination in the Matrigel invasion assay (Fig. 7c-d).
Comparison of the total number of invading cells re-
vealed that cells in the clone mixture were significantly
more effective at invading than the cells from the clone
GFP C3 alone (Fig. 7c). To estimate the contribution of
each clone to this increased invasive capacity, we must
take into consideration that although the total number
of seeded cells was the same as when we seeded a single
clone (30,000 cells), the number of cells from each clone
in the mix represents only 50% of the cells when seeded
individually (15,000 GFP C3 cells + 15,000 mKO E10
cells). Normalization of the data revealed that the
invasive capacity of the clone GFP C3 increased two-
fold when seeded together with the clone mKO E10 (Fig.
7d).
To determine if the increased invasion was the result
of physical interactions among clonal cell lines or se-
creted stimulatory factors, we performed the invasion
assay with GFP C3 and mKO E10 clonal cell lines
seeded individually, adding complemented medium
under the insert. We compared the invasion efficiency in
the presence of their own complemented medium or
medium complemented by the other clonal line, and
found that invasion also increased in the presence of
medium complemented by the other cell line (Fig. 7e).
To confirm these data in a more physiological context,
we performed an assay to measure cell dissemination in
the tail of zebrafish. Cells of the different clones were
injected alone (300 cells) or in combination (150 GFP
C3 cells + 150 mKO E10 cells) into the duct of Cuvier
and the number of cells in the tail after 72 h was deter-
mined (Fig. 7f-i). We found that co-injection of both
clonal cell lines resulted in significantly more cells in the
tail of the fish than injection of individual clonal cell
lines (Fig. 7f-g). In addition, a significant increase in the
(See figure on previous page.)
Fig. 5 DNA methylation profile of MDA-MB-231 clonal cell lines. a Heatmap of the most differentially methylated CpGs (delta ≥0.20) localized at
promoter, CpG island and shore regions (12,201 CpGs). b-c Identification of genes whose expression changes could be explained by methylation
differences: (b) downregulated vs hypermethylated and (c) upregulated vs hypomethylated. d Venn diagrams of methylation gene changes of
selected clonal cell lines vs. MDA-MB-231. e-f Gene Ontology (e) and KEGG (f) with differentially methylated genes (delta ≥0.20) at promoter and
CpG island and shore
Fig. 6 Cytokine expression. a Heatmap with clustering of released cytokines from the previous clonal cell lines. b Released cytokine mRNA and
protein levels vs receptor levels
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disseminating capacity of both clones was observed
(four-fold GFP and two-fold mKO) when the number of
injected cells was normalized for the respective condi-
tions (Fig. 7h). The efficiency of the injection did not
show significant differences between individual and co-
injected cells (Additional file 5: Figure S4g), excluding
injection efficiency as the cause of the differences in in-
vasion. Determination of the number of fish that con-
tained either both or only one of the clones after co-
injection revealed that 40% of fish had a combination of
GFP C3 and mKO E10, 9.95% had GFP C3 only and
10.29% had mKO E10 only (Fig. 7i), confirming that
communication between the cells of the different clones
and physical interaction account for the positive effect in
dissemination.
Effect of secreted factors on cell growth
We aimed to determine if cell growth could be modified
by secreted factors.
Cell growth in the presence of conditioned medium
To study the effect of secreted factors (including cyto-
kines and vesicles), conditioned medium (cell culture
supernatant obtained after 96 h of culture) was applied
in different concentrations to the individual cell lines
and the growth rates were determined by MTT. The
growth of the clonal cell lines mKO E10 and Sapphire
D7 as well as the parental cell line increased with the
conditioned medium from all other cell lines in a dose-
dependent manner (Fig. 8a-d). These results therefore
suggest that paracrine signaling promotes cell growth
(Fig. 8a-d). While this growth-supporting effect of con-
ditioned medium has long since been known, it was in-
teresting that the clonal cell line GFP C3 did not
significantly respond to any of the applied media. We
could suppose that GFP C3, as the faster clonal cell
line, does not require additional supplements from
other cell lines. The consequence of this lack of re-
sponse is shown in co-culture with cells with a similar
growth rate. In Fig. 7a and Additional file 4: Figure
S4b-c we see how the GFP C3 population decreases
faster in the presence of MDA-MB231, comparing the
percentage of observed populations (experimentally)
and expected population (calculated from proliferation
rate when the clonal cell line is cultivated individually).
We observed this phenomenon when MDA-MB231
and GFP C3 were cultured together and in the presence
of a third and even a forth clonal cell line. As we have
shown, GFP C3 proliferation does not increase with
medium complementation from other cell lines, how-
ever all the other cell lines do (Fig. 8a-d). The lack of
response of GFP C3 to medium complementation can
modify the expected evolution of the clonal compos-
ition: instead of being maintained at the same per-
centage as MDA-MB-231 (expected), GFP C3 is
progressively reduced.
Extracellular vesicle induced cell growth To identify
factors responsible for the increased metabolic rates upon
treatment with conditioned medium, we isolated extracel-
lular vesicles from the conditioned medium by ultracentri-
fugation. We confirmed that all the clonal cell lines were
able to release factors that increase metabolic rate (Fig.
7a-d) and that selected clonal cell lines were also able to
release exosomes (Additional file 6 Figure S5). We se-
lected the parental cell line as the exosome donor based
on our previous results: (1) analysis of vesicle size and
protein composition did not reveal major differences in
the vesicles isolated from the parental cell line and the in-
dividual clones (Additional file 6: Figure S5a-e) and (2) cell
lines responded positively to the addition of the factors,
independently of the donor (Fig. 8a-d). Isolated extracellu-
lar vesicles from the parental cell line were then added to
the parental cell line and the effect on cell growth was de-
termined. Addition of increasing amounts of vesicles to
the cells modified the metabolic rate of the receiving cells
(Fig. 8e). The maximal increase in metabolic activity was
observed with concentrations up to 1.25 μg exosome pro-
tein/mL. Higher concentrations of vesicles decreased the
effect on metabolic activity. Thus, extracellular vesicle
fractions contain factors that can modify the metabolic ac-
tivity of the receiving cells in a dose-dependent manner.
(See figure on previous page.)
Fig. 7 Clone interactions among parental and clonal cell lines in co-culture for 28 days (a-b). a Expected population percentage of total
population calculated using cumulative population doublings (CPDs) per day vs. observed population percentage. b CPDs/day of single culture
vs. CPDs/day of the same cell line in co-culture. c-e Cooperation of GFP C3 and mKO E10 in invasion assays: (c-d) Evaluation of cooperation on
the invading capacity of single clones vs co-cultured clones: (c) Total number of invading cells and (d) Relative ratio of invading cells based on
the cell number per clone cultured individually. (e) Invading capacity of cells conditioned with their own medium or medium from another
clonal cell line. Relative ratio of invading cells based on the cell number per clone cultured with their own conditioned medium. (f-i) In vivo
clonal cooperation. Cooperation of GFP C3 and mKO E10 in in vivo migration assays (Zebra fish model). Disseminated cells from the duct of
Cuvier to the tail 72 h after injection: individual injection of GFP C3 and mKO E10 and co-injection of both clonal cell lines: (f) Total number of
disseminated cells, (g) representative graph (scale bar = 70 μm), (h) relative ratio of invading cells based on the initial cell number per clone, (i)
analysis of the coexistence of clones in the co-injected fish: percentage of co-injected fish with GFP C3 cells only, mKO E10 cells only, or both.
Significant differences were determined using unpaired t-test with Welch’s correction. Asterisks indicate significant differences when P-values are
< 0.05 (*), < 0.01 (**), and < 0.001 (***)
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Fig. 8 Clone communication by released soluble factors. a-d Metabolic activity by MTT assay of clonal cell lines, 72 h after medium
complementation with supernatant extracted from MDA-MB-231, GFP C3, mKO E10 and Sapphire D7 cell line. Each graph corresponds to a cell
line donor medium, (a) MDA-MB-231, (b) GFP C3, (c) mKO E10 and (d) Sapphire D7. Color bars indicate the receiving cell line. e Metabolic activity
measurement of MDA-MB-231 by MTT assay after complementation with non-complemented medium (C-), 50% complemented medium (CM)
and exosomes. Significant differences were determined using unpaired t-test with Welch’s correction. Asterisks indicate significant differences
when P-values are < 0.05 (*), < 0.01 (**), and < 0.001 (***)
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Discussion
Breast cancer is the most frequently diagnosed neoplasm
in women and a leading cause of cancer death [1, 2].
Intertumor heterogeneity is one of the greatest issues in
oncology, but it is not the only factor that makes patient
treatment difficult: variation within a single tumor –
intratumor heterogeneity – is also a key factor in deter-
mining the best treatment [51].
Cellular heterogeneity in established breast cell lines,
including the MDA-MB-231 cell line, has been described
previously [45, 52]. In this study we corroborate clonal
heterogeneity in the MDA-MB-231 cell line of breast
carcinoma, after the selection of clones marked with
fluorochromes, using the StarTrack system (Additional
file 1: Figure S1c). Clonal cell lines were selected to
study the relevance of clonal communication in tumoral
heterogeneity. The results from the experiments in vivo
and in vitro demonstrated that despite all the observed
phenotypic differences, the parental cell line, composed
of a mix of an undetermined high number of clones, was
equal or superior in terms of malignancy (tumor com-
position and metastasis) to the individual clonal cell
lines in all tested conditions. Because the parental cell
line is a mix of different clones, these results led us to
the hypothesis that the interplay between different clonal
populations within a heterogeneous population, by inter-
cellular communication and/or feature complementa-
tion, provides advantages over isolated clonal cell lines.
Our results show that the mix of three clonal cell lines
did not recover the features of a multiclonal population.
For the study of tumor heterogeneity, the subcloning
method limits the number of clones and makes reconsti-
tution of a highly multiclonal population difficult. There-
fore, the mix of several clones cannot be equated to a
multiclonal population; rather, a parental cell line must
be included to provide a true multiclonal population.
However, subcloning may be a suitable method for the
independent study of the single clones that constitute a
cancer cell line or tumor.
Selected clonal cell lines showed variations in cell morph-
ology (Fig. 1a, Additional file 2: Figure S2a), just as patholo-
gists observe variation between different regions of the
same tumor [53, 54]. The clonal cell lines also showed dif-
ferences at the biological (Fig. 1), tumorigenic (Figs. 2, 3,
Additional file 3: Figure S3) and molecular levels, and in
gene expression (Fig. 4), DNA methylation pattern (Fig. 5)
and cytokine expression (Fig. 6), with clear functional het-
erogeneity. Parental cells showed a faster growth rate (Fig.
1b-e) and biological aggressiveness – a greater presence in
metastases – than the clones we studied (Fig. 3, Additional
file 3: Figure S3). Our results show that the phenotypes of
the single derived clones were heritable in the conditions
used in this study; however, culturing subclones for a longer
time could induce phenotypic changes if molecular or
epigenetic alterations accumulated. In such a situation, her-
itability could be tested by studying the phenotype of sub-
clones derived from the original clones, having cultured the
original clones for several months.
Moreover, in co-culture (Fig. 7, Additional file 5:
Figure S4a-c) the parental cells grew faster than the
single clones, indicating that the parental cell line
harbors a sum of clones that may outperform single
clones through local or secreted factors, as yet not
identified. These findings support the concept of the
whole is greater than the sum of its parts and de-
scribe a model where the interplay of clones confers
aggressiveness, and which may allow the identification
of factors involved in cellular communication and me-
tastasis. Thus, clonal heterogeneity allows the malig-
nant cell line to acquire the greatest malignant
potential.
Conventional models propose that each metastasis
originates from a single tumor cell [55–57]. However,
recent studies using mouse models of cancer have
demonstrated that multiple subclones undergo poly-
clonal seeding and demonstrate interclonal cooper-
ation between multiple subclones [7, 58]. Our results
confirm (Fig. 3d) that metastasis could be formed ei-
ther by a single (Fig. 3e) or several clonal cell lines
(Fig. 3d). However, even in cases of metastasis formed
by several clonal cell lines, each metastasis contained
one predominant clone (Fig. 3d). Comparative studies
indicate monoclonal patterns of seeding, suggesting
that clones compete to metastasize. However, poly-
clonal seeding, in which multiple clones from the pri-
mary tumor seed the same metastasis, is also
observed, indicating subclones might cooperate as
well as compete to metastasize [7, 59]. In our model
the cells were injected as a mix of single cells, there-
fore the metastasis formed by more than one cell line
originated from several cells that reached the lung to-
gether, demonstrating that the cells physically interact
to form the metastasis.
Several studies call into question the theory of clonal pro-
gression by the progressive accumulation of genetic alter-
ations and selection of more aggressive clones, supporting
instead the proposed theory of clonal cooperation between
tumor clones [20–23, 25–27]. Tumor multiclonality is also
supported by the field cancerization theory [60, 61], which
states that there are many genetic alterations in the normal
tissue surrounding tumors that can give rise to independent
clones. Similarly, supporting interpretations can be drawn
from the stem cell hypothesis, as diverse clones can derive
from more than one pluripotent stem cell [62, 63], and the
Big Bang model of colorectal tumor growth where the
tumor grows predominantly as a single expansion popu-
lated by numerous intermixed subclones [64]. Clonal co-
operation has recently been suggested in studies of single
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cell sequencing [62, 65, 66]. The present study further sup-
ports the idea that there are several clones that together
confer the properties of malignancy, thus strengthening the
concept of clonal cooperation, whereby clones synergistic-
ally provide certain selective advantages for proliferation,
resistance to apoptosis, induction of angiogenesis, and
interaction with environmental factors and inflammatory
cells [20, 21, 30, 63].
Our results show that cells are able to interact and the
coexistence of clonal cell lines resulted in a positive ef-
fect (Fig. 7c-h). We could conclude that physical inter-
action between clones (Fig. 7c-h) and secreted factors
(Fig. 7e, Fig. 8a-e) favored the tumorigenic capacities of
the cells. Cells are able to secrete factors (Fig. 6a) and
send messages to surrounding and distant cells (para-
crine signaling). Studies of cellular communication in
breast cancer have demonstrated tumor cells’ abilities to
secrete factors increasing breast cancer cell proliferation
and metastasis [67, 68].
Recently, interesting discoveries have been made in the
field of paracrine signaling. Extracellular vesicles (EVs) have
been postulated as a highly efficient method to transform
cells. Several groups have demonstrated that EVs upregulate
prometastatic and tumor angiogenesis pathways [69], even
transforming normal cells into cancer cells [70, 71]. Our
complementation assay confirmed intercellular communi-
cation via factors released from the cells, but we could not
distinguish between soluble factors (such as cytokines) or
released EVs. Our results showed that exosomes were able
to modify growth rate (Fig. 8e). However, the soluble factors
seemed to be more efficient than EVs, as the effect of exo-
somes was dose-dependent.
Our results demonstrate how some clones, via soluble
factors, EVs and physical interactions, are able to induce in-
creased aggressiveness in other clones. Therefore, we can
conclude that the Darwinian clonal progression theory
should be complemented with a “cooperative model”,
where clones are able to interact and transfer “properties”
among one another.
In our study, the biological differences observed between
the different clones have been corroborated by clear differ-
ences in the RNA expression arrays (Fig. 4), which were
complemented with methylomic studies (Fig. 5). We have
also demonstrated clonal communication (Figs. 7, 8), and
the challenge now is to identify the factors released by the
parental cells that enhance survival and metastasis. The
identification of factors and cytokines that modulate cellular
communication and enhance malignant properties will be
essential to understand the formation of clonal clusters and
prevent metastasis. We propose the term functional hetero-
geneity to highlight the different expression between clones
due to extracellular factors and epigenetic changes. This ap-
proach opens the way to new paradigms in the development
of metastases, including central factors at an intracellular
level, and factors involved in the communication between
tumor cells and microenvironmental or inflammatory cells.
In summary, these data support that functional clonal
heterogeneity does not always reflect genetic heterogeneity.
Inhibition of clonal cooperation, by blocking cytokines or
other factors involved in the formation of clusters and the
interplay with environmental cells may represent a change
in the therapeutic paradigm to prevent the development of
metastasis [21].
Conclusions
Interplay between clones confers malignancy, supporting
the concept of clonal cooperation, whereby clones synergis-
tically provide certain selective advantages by physical inter-
action, soluble factors and extracellular vesicles.
Additional files
Additional file 1: Figure S1. Generation of fluorescent clonal cell lines.
a. Mechanism to induce the expression of fluorescent proteins by
transposon integration. b. Fluorescent proteins codified by transposons.
c. Representative images of the clonal cell lines (scale bar = 50 μm)
obtained by transposon integration and subcloning: phase contrast and
specific fluorescence for every clonal cell line. (PDF 994 kb)
Additional file 2: Figure S2. Phenotypic characterization of MDA-MB-
231 GFP C3, mKO E10, and Sapphire D7 cell lines. a. Morphological evalu-
ation by phase contrast images (scale bar = 200 μm). b. Cumulative popu-
lation doublings per day (CPDs) (relative to MDA-MB-231 CPDs at 7 days
in culture) at 7, 14, 21 and 28 days in culture. c-d. Migration capability by
wound healing assay: measurements relative to MDA-MB-231 (c) and rep-
resentative images (scale bar = 200 μm) (d). Significant differences were
determined using ANOVA (Tukey’s multiple comparisons test) (b) and
Tukey’s unpaired t-test with Welch’s correction (c). Asterisks indicate sig-
nificant differences when P-values are < 0.05 (*), < 0.01 (**), and < 0.001
(***). (PDF 1639 kb)
Additional file 3: Figure S3. Homing capacity of parental, clonal cell
lines and an equal mix of all cell lines. Analysis of lung metastasis.
Hematoxylin/eosin staining. Complete lung reconstruction (scale bar =
400 μm). (PDF 823 kb)
Additional file 4: Table S1. Analysis of mKO mRNA expression vs MDA-
MB-231 with the Human Cancer Metastasis Database. (PDF 511 kb)
Additional file 5: Figure S4. Clone interactions among parental and
clonal cell lines: Co-culture for 28 days. a. Percentage of total population
represented by clonal cell lines and MDA-MB-231 at 0, 7, 14, 21 and 28
days in co-culture. b-c. Expected (E) percentage of total population calcu-
lated using CPDs per day vs. observed (O) population percentage: (b) Co-
culture of two clonal cell lines and (c) co-culture of three cell lines. d-f. Ef-
fect of arsenite on co-culture: (d) Proliferation 72 h after arsenite treat-
ment (250 μM-90 min). (e-f) Percentage of cell line populations after
arsenite treatment: (e) MDA-MB-231 vs GFP C3, (f) MDA-MB-231 vs mKO
E10. The percentage of each cell line in the total population was de-
tected at seeding (day 0), 90 min (day 1) and 72 h (day 4) after treatment.
g. Co-injection in zebra fish model: percentage of fish with cells in the
tail 72 h after injection with individual clones or co-injected with the mix.
Significant differences were determined using Tukey’s unpaired t-test
with Welch’s correction (b, c, d, e, f). Asterisks indicate significant differ-
ences when P-values are < 0.05 (*), < 0.01 (**), and < 0.001 (***). (PDF 917
kb)
Additional file 6: Figure S5. Clone communication by exosomes. a-c.
Characterization of exosomes: (a) area, (b) perimeter and (c) diameter.
Significant differences were determined using unpaired t-test with
Welch’s correction. Asterisks indicate significant differences when P-values
are < 0.05 (*), < 0.01 (**), and < 0.001 (***). d. Representative transmission
Martín-Pardillos et al. BMC Cancer          (2019) 19:666 Page 23 of 26
electron microscopy image of exosomes. e. Immunoblot of exosome
markers (TSG101 and CD81) and housekeeping gene (β-actin). (PDF 868 kb)
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